ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 110 filers reported holding ENZO BIOCHEM INC in Q1 2017. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $43,000 | -33.8% | 7,880 | -0.6% | 0.01% | -50.0% |
| Q4 2017 | $65,000 | -21.7% | 7,925 | 0.0% | 0.02% | -25.0% |
| Q3 2017 | $83,000 | -4.6% | 7,925 | 0.0% | 0.02% | +14.3% |
| Q2 2017 | $87,000 | -53.7% | 7,925 | -64.7% | 0.02% | -53.3% |
| Q1 2017 | $188,000 | -87.9% | 22,420 | -90.0% | 0.04% | -88.4% |
| Q4 2016 | $1,554,000 | +35.2% | 223,931 | -0.8% | 0.39% | +34.8% |
| Q3 2016 | $1,149,000 | +114800.0% | 225,834 | +126064.2% | 0.29% | – |
| Q1 2015 | $1,000 | – | 179 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,736,719 | $9,414,000 | 13.61% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $17,805,000 | 8.40% |
| Evermore Global Advisors, LLC | 2,605,607 | $8,963,000 | 6.32% |
| KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $328,000 | 0.19% |
| CORRADO ADVISORS, LLC | 46,816 | $161,000 | 0.12% |
| MYDA Advisors LLC | 35,000 | $120,000 | 0.03% |
| Cutter & CO Brokerage, Inc. | 29,827 | $103,000 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 258,700 | $890,000 | 0.02% |
| Paradigm Financial Partners, LLC | 18,000 | $62,000 | 0.02% |
| Renaissance Technologies | 3,340,864 | $11,493,000 | 0.01% |